Greystone, Thanks for your reply. I was thinking that in case of the Eureka spin-off onto a Nasdaq listing, perhaps Eureka’s contribution is to pay the cost of further trials and registration. Then a profit share. Because all of these trials will cost big dollars. That’s just a guess. Who knows until the announcements drop.
I do think your on the right track that next year will be big for deals.
Ann: Imugene Investor Presentation, page-16
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $271.5K | 4.939M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 3513888 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 146489 | 6 |
View Market Depth
| Last trade - 12.17pm 29/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |